Literature DB >> 21391902

Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities.

Valerio Chiurchiù1, Mauro Maccarrone.   

Abstract

A chronic inflammatory disease is a condition characterized by persistent inflammation. A number of human pathologies fall into this category, and a great deal of research has been conducted to learn more about their characteristics and underlying mechanisms. In many cases, a genetic component has been identified, but also external factors like food, smoke, or environmental pollutants can significantly contribute to worsen their symptoms. Accumulated evidence clearly shows that chronic inflammatory diseases are subjected to a redox control. Here, we shall review the identity, source, regulation, and biological activity of redox molecules, to put in a better perspective their key-role in cancer, diabetes, cardiovascular diseases, atherosclerosis, chronic obstructive pulmonary diseases, and inflammatory bowel diseases. In addition, the impact of redox species on autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and celiac disease) and neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis) will be discussed, along with their potential therapeutic implications as novel drugs to combat chronic inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391902     DOI: 10.1089/ars.2010.3547

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  57 in total

1.  Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.

Authors:  Chun-Yan Wang; Jing-Wei Xie; Ye Xu; Tao Wang; Jian-Hui Cai; Xu Wang; Bao-Lu Zhao; Li An; Zhan-You Wang
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

2.  Radical innate regulation of autoimmune diabetes.

Authors:  Dmitry V Ostanin; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2012-02-26       Impact factor: 7.376

Review 3.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

Review 4.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

5.  N6-(2-hydroxyethyl)-adenosine from Cordyceps cicadae attenuates hydrogen peroxide induced oxidative toxicity in PC12 cells.

Authors:  Leguo Zhang; Tao Wu; Opeyemi Joshua Olatunji; Jian Tang; Yuan Wei; Zhen Ouyang
Journal:  Metab Brain Dis       Date:  2019-06-13       Impact factor: 3.584

6.  Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.

Authors:  Elisa Bisicchia; Valerio Chiurchiù; Maria Teresa Viscomi; Laura Latini; Filomena Fezza; Luca Battistini; Mauro Maccarrone; Marco Molinari
Journal:  Cell Mol Life Sci       Date:  2013-01-08       Impact factor: 9.261

7.  Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response.

Authors:  Peng Li; Zhaohui Li
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

8.  Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs.

Authors:  Elisa Bisicchia; Valeria Sasso; Giuseppina Catanzaro; Alessandro Leuti; Zein Mersini Besharat; Martina Chiacchiarini; Marco Molinari; Elisabetta Ferretti; Maria Teresa Viscomi; Valerio Chiurchiù
Journal:  Mol Neurobiol       Date:  2018-01-22       Impact factor: 5.590

Review 9.  Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Authors:  Shokouh Arjmand; Zohreh Vaziri; Mina Behzadi; Hassan Abbassian; Gary J Stephens; Mohammad Shabani
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  The Novel Potential Therapeutic Utility of Montelukast in Alleviating Autistic Behavior Induced by Early Postnatal Administration of Thimerosal in Mice.

Authors:  Lobna A Abdelzaher; Ola A Hussein; I E M Ashry
Journal:  Cell Mol Neurobiol       Date:  2020-04-17       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.